SCHEMBL13978043

SCHEMBL13978043

O=C(O)c1ccnc2c(SSc3cccc4c(C(=O)O)ccnc34)cccc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PSMD14 O00487 5/20 1.00
▸ KDM4E B2RXH2 7/20 0.66
▸ L3MBTL1 Q9Y468 4/20 0.66
▸ KDM4A O75164 2/20 0.66
▸ EGLN1 Q9GZT9 2/20 0.66
▸ RAB9A P51151 1/20 0.66
▸ HIF1AN Q9NWT6 1/20 0.66
▸ KDM4C Q9H3R0 2/20 0.57
▸ KDM6B O15054 1/20 0.57
▸ KDM6A O15550 1/20 0.57
▸ TET3 O43151 1/20 0.57
▸ KDM4B O94953 1/20 0.57
▸ KDM5C P41229 1/20 0.57
▸ KDM4D Q6B0I6 1/20 0.57
▸ TET2 Q6N021 1/20 0.57
▸ ALKBH5 Q6P6C2 1/20 0.57
▸ TET1 Q8NFU7 1/20 0.57
▸ FTO Q9C0B1 1/20 0.57
▸ KDM2A Q9Y2K7 1/20 0.57
▸ KDM3A Q9Y4C1 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18541841 0.87 PSMD14 (0.77) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL18539683 0.87 PSMD14 (0.77) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL15703105 0.87 PSMD14 (0.77) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL13977968 0.83 PSMD14 (0.71) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL69905 0.82 KDM4E (0.74) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL28105356 0.82 PSMD14 (0.69) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL298623 0.79 KDM4E (1.00) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL18541842 0.79 PSMD14 (0.64) PSMD14KDM4EL3MBTL1KDM4AEGLN1
SCHEMBL13978047 0.79 PSMD14 (0.71) PSMD14L3MBTL1EGLN1LMNAHPGD
SCHEMBL23754362 0.78 KDM4E (0.68) PSMD14KDM4EL3MBTL1KDM4AEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 — — US disclosed
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 — — US disclosed
WO-2014066506-A2 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-05-01 — — WO disclosed
WO-2012158435-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION ZHOU HAN-JIE (US) 2012-11-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION USP24, USP36, USP39 PSMD14 7/4885KDM4E 2753/4885L3MBTL1 947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback